Randolph Sophia has filed 7 insider transactions across 1 company since December 2023.
Most recent transaction: a sale of 1365 shares of ALX ONCOLOGY HOLDINGS INC ($ALXO) on August 14, 2024.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 14, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Randolph Sophia | CHIEF MEDICAL OFFICER | S | Common Stock | 1365 | $2.58 | 325,711.0000 | 0 | 0.42% | 0.00% |
| July 1, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Randolph Sophia | CHIEF MEDICAL OFFICER | S | Common Stock | 3273 | $5.82 | 327,076.0000 | 0 | 0.99% | 0.00% |
| May 13, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Randolph Sophia | CHIEF MEDICAL OFFICER | S | Common Stock | 10203 | $15.82 | 332,146.0000 | 0 | 2.98% | 0.00% |
| May 13, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Randolph Sophia | CHIEF MEDICAL OFFICER | S | Common Stock | 1797 | $16.67 | 330,349.0000 | 0 | 0.54% | 0.00% |
| Feb. 14, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Randolph Sophia | CHIEF MEDICAL OFFICER | A | Common Stock | 30000 | $0.00 | 342,349.0000 | 0 | 9.60% | 0.00% |
| Feb. 14, 2024 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Randolph Sophia | CHIEF MEDICAL OFFICER | A | Employee Stock Option (right to buy) | 95000 | $0.00 | 95,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 29, 2023 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Randolph Sophia | Chief Medical Officer | S | Common Stock | 3128 | $15.04 | 312,349.0000 | 0 | 0.99% | 0.00% |